ND

Natasha Dipen Kothari

Active Director Director DIN 07146608
DIN 07146608 First appointment May 2015 Primary industry Internet
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since May 2015
Shareholding value •••• Premium profile

About Natasha Dipen Kothari

Data last updated:

Natasha Dipen Kothari is a Director at Zeva Capsol Private Limited (since 2015), Director at Greenjams Buildtech Private Limited (since 2025) and Nominee Director at Synthera Biomedical Private Limited (since 2018). The companies operate in Internet, Manufacturing and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹4.67 Cr; the largest is Zeva Capsol Private Limited at ₹3.64 Cr (FY 2025). Earlier, Natasha Dipen Kothari was a Nominee Director at Konverge Healthcare Private Limited (2019–2020).

DIN 07146608
Primary Designation Director
Industry Internet
First Appointment 01 May 2015
Oldest Company Age 11 yrs
Largest company Zeva Capsol Private Limited · ₹3.64 Cr (FY 2025)
Combined revenue ₹4.67 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zeva Capsol Private Limited U74900MH2015PTC264012
Director01 May 20152015₹3.64 Cr (FY 2025)Active
Greenjams Buildtech Private Limited U45400AP2019PTC113262
Director21 Jun 20252019₹1.02 Cr (FY 2025)Active
Synthera Biomedical Private Limited U33111PN2015PTC155498
Nominee Director15 Jun 20182015₹1.5 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Konverge Healthcare Private Limited U24232KA2014PTC077624
Nominee Director27 Aug 20192014₹10.11 Cr (FY 2020)Under Cirp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Synthera Biomedical Private Limited
Zeva Capsol Private Limited
Greenjams Buildtech Private Limited
Konverge Healthcare Private Limited
Premium access

Shareholding and investment profile for Natasha Dipen Kothari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Natasha Dipen Kothari

Natasha Dipen Kothari currently holds 3 directorships: Zeva Capsol Private Limited (Director, since 01 May 2015, revenue ₹3.64 Cr (FY 2025)); Greenjams Buildtech Private Limited (Director, since 21 Jun 2025, revenue ₹1.02 Cr (FY 2025)); Synthera Biomedical Private Limited (Nominee Director, since 15 Jun 2018, revenue ₹1.5 Lakh (FY 2025)).

Natasha Dipen Kothari was first appointed on 01 May 2015 as Director at Zeva Capsol Private Limited. The most recent appointment on record is 21 Jun 2025 at Greenjams Buildtech Private Limited.

The 3 current companies of Natasha Dipen Kothari that report revenue have a combined latest revenue of ₹4.67 Cr: Zeva Capsol Private Limited ₹3.64 Cr (FY 2025); Greenjams Buildtech Private Limited ₹1.02 Cr (FY 2025); Synthera Biomedical Private Limited ₹1.5 Lakh (FY 2025).

Natasha Dipen Kothari held 1 earlier board appointment: Konverge Healthcare Private Limited (Nominee Director, 27 Aug 2019 to 01 Dec 2020).

The current boards of Natasha Dipen Kothari's companies include Anil Gudibande (Zeva Capsol Private Limited), Anup Thomas Kuruvilla (Zeva Capsol Private Limited), Ganesh Natarajan (Zeva Capsol Private Limited), Girichandra Sureshchandra Kuchangi (Zeva Capsol Private Limited), Niravbhai Dineshbhai Jogani (Zeva Capsol Private Limited), Sujit Banerji (Zeva Capsol Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available